Medical Devices APAC

APAC Intragastric Balloon Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

APAC Intragastric Balloon Market Industry Trends and Forecast to 2034: Segmented by (Type, Filling, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $57.5 Mn Placeholder estimate
Estimate 2025 $64.7 Mn 21% of the global market
Projected 2034 $186.7 Mn 188.7% Adds $122.0 Mn over 9 forecast years
CAGR 2025–2034 12.5% Faster than 67% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • APAC is 21% of the global market.
  • Among regions, the largest is North America at $145.1 Mn.
  • Fastest growing: Africa at 12.9% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$122.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Intragastric Balloon Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $57.5 Mn — —
2025 (base) $64.7 Mn +$7.2 Mn —
2026 (forecast) $72.8 Mn +$8.1 Mn +12.5%
2027 (forecast) $81.9 Mn +$9.1 Mn +26.6%
2028 (forecast) $92.1 Mn +$10.2 Mn +42.4%
2029 (forecast) $103.6 Mn +$11.5 Mn +60.2%
2030 (forecast) $116.5 Mn +$12.9 Mn +80.2%
2031 (forecast) $131.1 Mn +$14.6 Mn +102.7%
2032 (forecast) $147.5 Mn +$16.4 Mn +128.1%
2033 (forecast) $165.9 Mn +$18.4 Mn +156.6%
2034 (forecast) $186.7 Mn +$20.7 Mn +188.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Intragastric Balloon Market Analysis at a glance
Market size, 2025$64.7 Mn placeholder estimate
Forecast, 2034$186.7 Mn placeholder estimate
Growth (CAGR), 2025–203412.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, filling and end user (see all)
Key playersAllurion Technologies, Apollo Endosurgery, Spatz Medical, Obalon Therapeutics, Helioscopie (see all)
Active clinical trials2 in Asia PacificSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Asia Pacific. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Intragastric Balloon Market Analysis Executive Summary

Intragastric balloons are soft balloons placed in the stomach for a few months to help people eat less and lose weight without surgery.

Key segments of the intragastric Balloon market include type (Single Balloon, Dual Balloon and Swallowable Balloon) and filling (Saline-Filled and Gas-Filled).

Bar chart: Asia Pacific Intragastric Balloon market size, 2024–2034, placeholder estimates. $57.5 Mn in 2024, $64.7 Mn in 2025 and $186.7 Mn in 2034, 12.5% CAGR.
Asia Pacific Intragastric Balloon market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Intragastric Balloon Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the intragastric Balloon market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the intragastric Balloon market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the intragastric Balloon market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Intragastric Balloon Market in APAC

The intragastric Balloon market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Intragastric Balloon Market in APAC

Intragastric Balloon in APAC: rules, payment and research

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9] and Thai FDA (Thailand)⁠[10]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[11], basic medical insurance (China)⁠[12], the Hospital Authority (Hong Kong)⁠[13], Ayushman Bharat PM-JAY (India)⁠[14], public health insurance (Japan)⁠[15], subsidised public care (Malaysia)⁠[16], Pharmac (New Zealand)⁠[17], PhilHealth (Philippines)⁠[18], MediShield Life (Singapore)⁠[19] and the Universal Coverage Scheme (Thailand)⁠[20]. ClinicalTrials.gov lists 2 studies on Intragastric Balloon that are recruiting, active or about to start in APAC.⁠[21]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[12] National Healthcare Security Administration. Checked 14 Nov 2026.

[13] Hospital Authority. Checked 14 Nov 2026.

[14] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[15] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[16] Ministry of Health Malaysia. Checked 14 Nov 2026.

[17] Pharmac. Checked 14 Nov 2026.

[18] PhilHealth. Checked 14 Nov 2026.

[19] CPF Board, MediShield Life. Checked 14 Nov 2026.

[20] National Health Security Office. Checked 14 Nov 2026.

[21] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in APAC. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how intragastric Balloon products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Intragastric Balloon right now, from free public sources.

Clinical trials

2 active trials in China, India, Japan, Australia, Hong Kong, Philippines, Singapore, Thailand, Malaysia, New Zealand, Bangladesh, Afghanistan, Indonesia, Myanmar, Nepal and Pakistan

Recruiting, about to start, or running now. Counted across the 16 countries we report on in APAC.

Top trial sponsors (worldwide)

  1. Boston Scientific Corporation 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Patients

Obesity (adults), % of adults (WHO)
CountryValueYear
Afghanistan20.62024
Australia30.62024
Bangladesh5.82024
China9.32024
India8.02024
Indonesia11.82024
Japan5.92024
Malaysia23.32024
Myanmar8.12024
Nepal8.02024
New Zealand34.02024
Pakistan24.52024
Philippines9.62024
Singapore17.02024
Thailand16.42024
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Intragastric Balloon in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Intragastric Balloon market in Asia Pacific?
Placeholder estimate: about $64.7 Mn in 2025, rising to about $186.7 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Intragastric Balloon market in Asia Pacific growing?
Placeholder estimate: about 12.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Intragastric Balloon market report cover?
The report splits the market by type (Single Balloon, Dual Balloon, Swallowable Balloon), filling (Saline-Filled, Gas-Filled) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Intragastric Balloon market?
Key players include Allurion Technologies, Apollo Endosurgery, Spatz Medical, Obalon Therapeutics and Helioscopie.
What is driving the Intragastric Balloon market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the intragastric Balloon market.
How many clinical trials on Intragastric Balloon are running in Asia Pacific?
2 studies are recruiting, active or about to start in Asia Pacific, counted across the 16 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Asia Pacific. Retrieved 12 Nov 2026.
How much research is published on Intragastric Balloon?
PubMed lists 302 papers on Intragastric Balloon added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on obesity and diabetes

See the topic